ReviewClinical and experimental dermatology2022
Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature.
Review in Clinical and experimental dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.
- Meningitis after COVID-19 vaccination, a systematic review of case reports and case series.BMC infectious diseases · 2024Pooled it
- Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Pooled it
- SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.International journal of dermatology · 2022Pooled it
- Linear IgA bullous dermatosis in a child after the second dose of inactivated COVID-19 vaccine.Postepy dermatologii i alergologii · 2025Article
- Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system.Frontiers in medicine · 2025Article
- New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review.Vaccines · 2024Review
- [Blisters in a "cluster of jewels"-like pattern in a child with chronic hepatitis B infection].Dermatologie (Heidelberg, Germany) · 2024Article
- Linear IgA bullous dermatosis after COVID-19 vaccination.International journal of dermatology · 2023Article
- Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine.Journal of cutaneous pathology · 2023Article
- Side effects of COVID-19 vaccines in the middle eastern population.Frontiers in immunology · 2023Review
- Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine.Frontiers in medicine · 2023Review
- Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.Journal of autoimmunity · 2022Review
- Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study.Journal of cosmetic dermatology · 2022Article
- Significance of digestive symptoms after COVID-19 vaccination: A retrospective single-center study.The American journal of emergency medicine · 2022Article
- Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022Observational
- Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.Pathology, research and practice · 2022Review
- Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review.Microorganisms · 2022Review
- Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review.Clinical and experimental dermatology · 2022Review
- Linear IgA bullous dermatosis following Oxford AstraZeneca COVID-19 vaccine.Clinical and experimental dermatology · 2022Article
- SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist.Current dermatology reports · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.